News | Breast Density | March 06, 2019

South Dakota's Density Inform Bill Signed Into Law

South Dakota becomes 37th state with active breast density inform legislation

South Dakota's Density Inform Bill Signed Into Law

March 6, 2019 – With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which was signed on March 5, 2019 by Gov. Kristi Noem, goes into effect July 1, 2019.

South Dakota Rep. Taffy Howard introduced the legislation after becoming alarmed about the inconsistency of density notification across the state and the lack of information about the risks associated with dense breasts.

“Breast density is a critical piece of information regarding a woman’s breast health, but women are reliant upon their healthcare provider for this information, which is why this legislation was so vital. Many women across this state are informed by their provider about their breast density, but not all. This bill ensures all women across South Dakota are informed as to their breast density. It will also provide additional information if they are in one of the two higher levels of density and encourage women to discuss findings with their primary care providers,” said Howard.

Approximately 40 percent of women aged 40 and over have dense breast tissue that may hide cancers on mammography. Women with dense breasts may benefit from supplemental screening tests, in addition to mammography, to detect cancers. Women with extremely dense breasts are also 4-6 times more likely to develop breast cancer than women with the least dense breasts. Providing women with their breast density classification would enable them to initiate discussions with their physicians about whether supplemental screening might be beneficial.

“Sen. Deb Soholt was tremendously helpful in getting key players on board,” continued Howard. “I am tremendously grateful to JoAnn Pushkin, executive director of for all her hard work in calling attention to this issue and, along with Jill Schultz, with Avera Breast Center, for providing outstanding testimony in support of the bill. We all have an obligation to fight this disease in whatever way we are able, and I was glad to be able to aid in a small way in that fight.”                    

South Dakota’s state law follows the Feb. 15, 2019 passage of federal legislation directing the U.S. Food and Drug Administration (FDA), through the regulatory process, to develop reporting language and ensure that mammography reports and summaries received by patients and their providers include appropriate information about breast density. The timeline for implementation of federally mandated reporting language is unknown; however, once the new standard is introduced, individual state law review will be necessary.

Read the article "Congress Directs FDA to Establish Federal Breast Density Inform Standard"

For more information:

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...